Product image of Lacosamide Accord (Lacosamide) supplied by GNH India

Lacosamide Accord

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamide Accord (Lacosamide)

Lacosamide, the active ingredient in Lacosamide Accord, is a sodium channel blocker presented as an injection for intravenous use. It treats partial‑onset seizures in patients with epilepsy.

GNH India supplies Lacosamide Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacosamide is an antiepileptic drug that acts on neuronal sodium channels to control seizure activity.

  • Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy.
  • Adjunct therapy in refractory epilepsy: added when seizures are not adequately controlled by other antiepileptics.
  • Secondary generalized seizures: helps prevent progression of focal seizures to generalized convulsions.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing hyperexcitable neuronal membranes and limiting repetitive neuronal firing that underlies seizure generation.

Side Effects

Lacosamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Nausea: feeling of stomach upset or urge to vomit.
  • Headache: mild to moderate pain in the head region.
  • Fatigue: unusual tiredness or lack of energy.
  • Blurred vision: temporary visual disturbances.
  • Somnolence: increased sleepiness during the day.

Serious or Rare Side Effects

  • Cardiac arrhythmia: irregular heart rhythm, including atrioventricular block.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hypersensitivity: rash, swelling, or anaphylactic response.
  • Respiratory depression: slowed breathing, especially with concomitant depressants.
  • Suicidal thoughts: emergence of depressive or suicidal ideation.
  • Severe hypotension: marked drop in blood pressure.

Precautions & Warnings

When using Lacosamide Accord, clinicians should consider several safety aspects.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Cardiac conduction disorders: obtain baseline ECG and watch for arrhythmias.
  • Pregnancy: prescribe only if potential benefit justifies potential risk to the fetus.
  • Concomitant CNS depressants: observe for enhanced sedation or respiratory effects.
  • Hypersensitivity: discontinue immediately if allergic reaction occurs.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Lacosamide can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors: may increase lacosamide plasma concentrations.
  • Class I antiarrhythmics: additive effects on cardiac conduction.
  • Other sodium channel blockers: heightened risk of central nervous system depression.

Moderate Interactions (Monitor Closely)

  • Carbamazepine: may reduce lacosamide levels, decreasing effectiveness.
  • Phenytoin: can alter lacosamide plasma concentrations.
  • Alcohol: may potentiate CNS side effects such as dizziness and somnolence.

Frequently Asked Questions

Lacosamide Accord is an intravenous formulation of the antiepileptic drug lacosamide. It is used to treat partial‑onset (focal) seizures in patients with epilepsy, either as monotherapy or as an adjunct to other antiepileptic medications.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes. This stabilizes hyper‑excitable neurons, reduces repetitive firing, and thereby helps prevent the initiation and spread of seizure activity.

The specific dose and infusion rate of Lacosamide Accord are determined by the prescribing clinician based on the patient’s clinical condition, age, weight, renal function, and response to therapy. Dosage should follow the prescriber’s instructions.

Safety data for lacosamide in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and import documentation.

Lacosamide belongs to the sodium channel blocker class and offers a distinct mechanism that enhances slow inactivation, unlike many older agents that target fast inactivation. It is generally well‑tolerated and may be preferred when patients experience side effects from other sodium‑blocking antiepileptics.

Lacosamide Accord should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vials in their original packaging until use to maintain stability.

The product is given by intravenous infusion. The rate and duration of infusion are set by the treating physician, typically over 15 minutes to an hour, depending on the clinical situation and patient tolerance.

Serious risks include cardiac arrhythmias such as atrioventricular block, severe skin reactions like Stevens‑Johnson syndrome, hypersensitivity reactions, respiratory depression when combined with other depressants, and the emergence of suicidal thoughts. Prompt medical attention is required if any of these occur.

Patients with known hypersensitivity to lacosamide or any component of the formulation should avoid it. Those with significant cardiac conduction abnormalities, uncontrolled severe renal impairment, or who are pregnant without a clear benefit should also be evaluated carefully before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.